ANI Pharmaceuticals | ANIP - Gross Profit On Sales


ANI Pharmaceuticals reported $143.88M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
ANI Pharmaceuticals USD 143.88M 19.7M Mar/2026
Aurora Cannabis CAD 29.79M 16.83M Mar/2026
Canopy Growth CAD 8.26M 13.2M Mar/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
Heron Therapeutics USD 29.47M 3.17M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Novartis USD 10.07B 758M Mar/2026
Omeros USD -33.16M 18.52M Jun/2024
Perrigo USD 313.9M 11.6M Jun/2026
Sun Pharmaceuticals INR 117.59B 7.65B Mar/2026
Teva Pharmaceutical Industries USD 2.15B 45M Jun/2026